Results 91 to 100 of about 27,883 (236)

First United States Experience With Focal Pulsed‐Field Ablation Using the FARAPOINT Catheter for Refractory Ventricular Tachycardia

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Drug‐refractory ventricular tachycardia (VT) after failed radiofrequency (RF) ablation remains a clinical challenge. Pulsed‐field ablation (PFA) is expanding to ventricular applications, but United States experience with focal pulsed‐field‐only catheters in VT is sparse, and pulsed‐field platforms are not equivalent across ...
Jorge L. Reyes   +3 more
wiley   +1 more source

Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum   +22 more
wiley   +1 more source

Validation of Cardiorespiratory‐Gated Proton Beam Delivery for Stereotactic Arrhythmia Radioablation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Stereotactic arrhythmia radioablation (STAR) with scanned proton beams was performed in a porcine model targeting the left ventricular free wall (A). Dual gating synchronized proton delivery with both respiratory and cardiac motion was compared to single gating using only respiratory motion (B).
Jagdip Kang   +17 more
wiley   +1 more source

Impact of Ganglionated Plexus Ablation on Early Recurrence After Thoracoscopic Atrial Fibrillation Ablation: A Post Hoc Analysis of the AFACT Study

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Adjunctive ganglionated plexus (GP) ablation did not reduce early AF recurrence after thoracoscopic AF ablation but was associated with a later first recurrence. In the GP‐ablation group, early recurrence was associated with late recurrence; this exploratory finding is compatible with, but does not establish, a greater contribution of pre‐existing ...
Zhenyu Dong   +11 more
wiley   +1 more source

Consensus‐Recommended Follow‐Up Mediates Cardiovascular Outcomes Disparities Between Implantable Cardioverter Defibrillator and Pacemaker Recipients

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Consensus‐recommended follow‐up after cardiac implantable electronic device (CIED) implantation improves outcomes, yet whether it mediates cardiovascular disparities between device types remains unknown. Methods We prospectively studied 6806 patients undergoing CIED implantation across a multi‐hospital system (2019–2023; median ...
Jingwen Huang   +3 more
wiley   +1 more source

Risks of Appropriate Implantable Cardioverter Defibrillator Therapy and Hospitalization Are Increased Around Device-Detected Atrial High-Rate Episodes Longer Than 6 min. [PDF]

open access: yesJ Arrhythm
Device‐detected atrial high‐rate episodes (AHREs) lasting ≥ 6 min identify a transient period of increased clinical risk in ICD patients. During the 60‐day peri‐AHRE period, risks of appropriate ICD shock, any appropriate ICD therapy, and cardiac hospitalization were significantly increased.
Nørgaard N   +3 more
europepmc   +2 more sources

Temporal Association Between Intrathoracic Impedance and Tachyarrhythmia Occurrence

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
A decrease in intrathoracic impedance is temporally associated with subsequent AF occurrence and, at the episode level, with a shorter time to VT. These findings suggest that daily intrathoracic impedance may provide information on short‐term changes preceding tachyarrhythmia occurrence.
Monika Butkuvienė   +5 more
wiley   +1 more source

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh   +9 more
wiley   +1 more source

Impact of ICD Presence in Patients With Left Ventricular Assist Devices for End‐Stage Heart Failure

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The prognostic relevance of implantable cardioverter defibrillator (ICD) in patients with end‐stage heart failure (HF) with left ventricular assist device (LVAD) remains controversial. Objectives To evaluate the prognostic impact of ongoing use of ICD and associated complications in HF‐patients with LVAD‐implantation.
Nafilah Baridwan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy